查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984127

神经外科手术室人工智慧市场：按组件、技术、部署方式、手术类型、目标部位、应用和最终用户划分——2026年至2032年全球市场预测

Artificial Intelligence in Neurology Operating Room Market by Component, Technology, Deployment, Surgery Type, Anatomy Target, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年，神经外科手术室人工智慧 (AI) 市场价值为 40.6 亿美元，预计到 2026 年将成长至 46.8 亿美元，复合年增长率为 16.08%，到 2032 年将达到 115.4 亿美元。

主要市场统计数据
基准年 2025 40.6亿美元
预计年份：2026年 46.8亿美元
预测年份 2032 115.4亿美元
复合年增长率 (%) 16.08%

权威说明，阐述人工智慧如何即时改变神经外科手术工作流程、术中决策和手术室效率。

手术室正朝着智慧化方向发展，人工智慧即时辅助手术决策、影像诊断和器械控制。在神经病学领域，这些进步与需要极高精度、动态术中成像以及生理和影像数据持续分析的手术密切相关。本执行摘要在于临床需求与人工智慧解决方案的交会点，说明这些技术如何整合重塑围手术全期工作流程和临床医师的工作环境。

诊断影像、导航、机器人技术和服务模式的进步融合，为神经外科手术室和采购系统带来了系统性的改变。

神经外科手术室的环境正在经历一场变革，这主要得益于感测技术、机器感知和机器人精准度的不断成熟。目前，成像系统能够提供高精度的资料流，人工智慧模型可在术中对这些资料进行分析，从而实现即时组织表征、切缘检测和导航校正。同时，导航平台与机器人系统和分析层的整合度也不断提高，推动手术领域朝向协作式、半自动的任务执行模式发展，进而减轻手术团队的认知负荷。

分析关税调整和贸易政策趋势如何重塑用于神经外科应用的人工智慧系统的供应链、筹资策略和采购实践。

政策变化和关税调整会对高度复杂的医疗技术领域的供应链、零件采购和筹资策略产生连锁反应。在近期关税措施和贸易不确定性下，製造商和医疗系统正面临零件成本上涨、前置作业时间延长且更难以预测，以及重新评估供应商集中度风险的必要性。包含精密机械部件、先进成像检测器或专用伺服马达的硬体组件尤其容易受到进口关税和贸易壁垒变化的影响。

从综合细分的观点，将组件、应用程式、使用者、技术、部署模型和手术方法连结起来，揭示采用的驱动因素和价值来源。

以细分观点，可以清楚阐明价值创造的来源，以及不同产品层级、临床应用和客户类型之间的投资重点差异。从组件层面来看，硬体仍然是基础，影像、导航和机器人系统构成了与患者和临床团队的直接接触点，而服务和软体则驱动着永续营运和临床价值提案。整合、维护和培训服务对于释放硬体的效用至关重要，而人工智慧平台、分析软体和预测演算法则是提升术中决策品质和工作流程效率的关键驱动因素。

美洲、欧洲、中东和非洲以及亚太地区的不同管理体制、采购模式和临床基础设施如何影响部署轨迹和供应商策略？

区域趋势对技术采纳、监管参与和临床检验过程有显着影响。在美洲，医疗保健系统通常优先考虑基于结果的采购、强大的机构研究网络以及对早期临床检验的投资意愿，这加速了试验计画和迭代部署。专业神经外科中心和集中式学术中心的存在也支持快速产生证据和开展临床医生培训倡议，从而促进技术的更广泛应用。

竞争对手与策略挑战：致力于透过整合解决方案、临床证据产生和创新经营模式。

主要企业的行动都围绕着几个策略重点展开，这些重点决定了它们的市场定位和长期竞争力。首先，能够整合端到端解决方案（将影像和导航硬体与检验的人工智慧软体以及强大的服务交付相结合）的企业，可以提高客户的转换成本，并为高额合约模式提供合理的依据。其次，临床系统整合商、影像设备供应商和专业人工智慧开发商之间的伙伴关係正逐渐成为加速监管申报和临床试验、以及共用风险和证据产生责任的标准模式。

为市场领导提供可操作的策略措施，以加速采用、降低采用风险，并使经营模式与临床结果和采购实际情况保持一致。

产业领导者必须采取一系列平衡的策略步骤，协调临床检验、采购流程复杂性和技术差异化。优先透过多中心研究和临床医生主导的初步试验来建立可验证的临床证据，这些试验不仅要衡量技术精确性，还要衡量对工作流程的影响、使用者接受度和后续临床结果。同时，制定商业提案，应将整合、培训和维护服务与硬体和软体捆绑销售，从而降低客户风险，减少早期采用者的营运摩擦。

结合临床医师访谈、技术评估、监管审查和供应链分析等多方面研究途径，得出基于证据的结论。

本报告的调查方法结合了初步研究和严谨的二次研究，并辅以临床检验，以确保研究结果具有实证性和可操作性。初步研究包括对第一线神经外科医生、手术室护士、生物医学工程师、医院采购负责人和技术部门主管进行结构化访谈，并在条件允许的情况下辅以对术中工作流程的直接观察。这些初步研究结果与设备技术规格、监管申报文件和同行评审的临床文献进行交叉比对，以检验结论并为结果提供背景资讯。

本文概述了临床检验、互通性设计和稳健的商业策略如何为人工智慧在神经外科领域的持续应用奠定基础。

人工智慧正从一项前景看好的辅助技术，发展成为支撑更安全、更精准的神经外科手术的基础层。这项技术的价值在于硬体精度、检验的演算法和服务模式的融合，从而降低术中不确定性，提高手术效率，并扩展专家知识。然而，实现这一愿景需要严格的临床检验、可互操作系统设计、稳健的供应链以及能够协调供应商和医疗服务提供者奖励的完善商业模式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：神经外科手术室人工智慧市场：按组件划分

  • 硬体
    • 医学影像系统
    • 导航系统
    • 机器人系统
  • 服务
    • 综合服务
    • 维护服务
    • 培训服务
  • 软体
    • 人工智慧平台
    • 分析软体
    • 预测演算法

第九章：神经外科手术室人工智慧市场：依技术划分

  • 电脑视觉
    • 三维重建
    • 影像分割
  • 深度学习
    • 卷积类神经网路
    • 循环神经网络
  • 机器学习
    • 监督式学习
    • 无监督学习
  • 自然语言处理
    • 临床报告分析
    • 文献挖掘

第十章：神经外科手术室人工智慧市场：以部署方式划分

  • 云
  • 现场

第十一章：神经外科手术室人工智慧市场（依手术类型划分）

  • 深部脑部刺激疗法
  • 癫痫手术
  • 肿瘤切除

第十二章：神经外科手术室人工智慧市场（依解剖科目划分）

  • 脑
  • 脊髓

第十三章：神经外科手术室人工智慧市场：按应用领域划分

  • 术中影像诊断
    • CT
    • MRI
    • 超音波
  • 预测分析
    • 结果预测
    • 工作流程优化
  • 机器人支援
    • 神经科学用内视镜机器人
    • 机器人辅助显微手术
  • 手术导引
    • 电磁导航
    • 光学导航

第十四章：神经外科手术室人工智慧市场：依最终用户划分

  • 门诊手术中心
  • 医院和诊所
  • 研究机构

第十五章：神经外科手术室人工智慧市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章：神经外科手术室人工智慧市场：按类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章：神经外科手术室人工智慧市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国神经外科手术室的人工智慧市场

第十九章：中国神经外科手术室的人工智慧市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Activ Surgical Inc.
  • Brainomix Limited
  • Caresyntax Corporation
  • DeepOR SAS
  • ExplORer Surgical Corp.
  • GE HealthCare Technologies, Inc.
  • Getinge AB
  • Hill-Rom Holdings, Inc.
  • Holo Surgical Inc.
  • IMRIS inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & CO. KG
  • Koninklijke Philips NV
  • LeanTaaS Inc.
  • Medtronic PLC
  • NeuroOne Medical Technologies Corporation
  • Proximie Limited
  • Scalpel Limited
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Surgalign Spine Technologies Inc.
  • Surgical Theater, Inc.
  • Theator Inc.
  • Toshiba Corporation
Product Code: MRR-5C6F41F5AF3E

The Artificial Intelligence in Neurology Operating Room Market was valued at USD 4.06 billion in 2025 and is projected to grow to USD 4.68 billion in 2026, with a CAGR of 16.08%, reaching USD 11.54 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.06 billion
Estimated Year [2026] USD 4.68 billion
Forecast Year [2032] USD 11.54 billion
CAGR (%) 16.08%

An authoritative orientation to how artificial intelligence is reshaping neurosurgical workflows, intraoperative decision-making, and operating room efficiency in real time

The operating room is evolving into an intelligent environment where artificial intelligence augments surgical decision-making, imaging interpretation, and device control in real time. In neurology, these advances intersect with procedures that demand extreme precision, dynamic intraoperative imaging, and continuous interpretation of physiological and imaging data. This executive summary frames the intersection of clinical imperatives and AI-enabled solutions, focusing on how technologies are converging to redefine perioperative workflows and clinician ergonomics.

Across procedural stages, AI is moving from adjunctive analytics toward embedded functionality that supports image-guided resection, robotic assistance, and predictive workflow orchestration. The content that follows distills core shifts in technology, clinical validation priorities, supplier models, and regulatory considerations that stakeholders must weigh. It is intended to orient senior executives, clinical leaders, and commercialization teams to the strategic choices that will determine adoption velocity and clinical impact over the coming years.

How converging advances in imaging, navigation, robotics, and service models are driving systemic transformation in neurosurgical operating rooms and procurement

The landscape of neurology operating theaters is experiencing transformative shifts driven by the maturation of sensing modalities, machine perception, and robotic precision. Imaging systems now feed high-fidelity data streams that AI models can analyze intraoperatively, enabling real-time tissue characterization, margin detection, and navigation corrections. Concurrently, navigation platforms are becoming more tightly integrated with robotic systems and analytics layers, moving the field toward coordinated, semi-autonomous task execution that reduces cognitive load on surgical teams.

These shifts are reinforced by expanding lines of service that accompany hardware and software deployments. Integration services are evolving to cover data orchestration and interoperability across legacy imaging modalities, while training and maintenance services are critical to sustain clinical confidence and uptime. As a result, business models are transitioning from pure capital equipment sales to bundled solutions that combine devices, predictive software, and ongoing clinical support. This systemic evolution is altering procurement criteria, clinician training curricula, and capital planning priorities across health systems.

Analysis of how tariff adjustments and trade policy dynamics are reshaping supply chains, sourcing strategies, and procurement behavior for neurosurgical AI systems

Policy changes and tariff adjustments can have cascading effects across supply chains, component sourcing, and procurement strategies for high-complexity medical technologies. In the context of recent tariff actions and trade uncertainties, manufacturers and health systems face upward pressure on component costs, longer and less predictable lead times, and the need to reassess supplier concentration risks. Hardware elements that incorporate precision mechanical components, advanced imaging detectors, or specialized servomotors are particularly exposed to shifts in import duties and trade barriers.

Over time, these pressures tend to accelerate supplier diversification and localization strategies, prompting device makers to onshore or nearshore key assembly and subassembly operations where feasible. Software and cloud-based services experience a different set of impacts: while they are less vulnerable to physical tariffs, they are affected by cross-border data transfer policies, hosting costs, and contractual obligations that can increase total cost of ownership. Health systems responding to procurement cost pressures may prioritize modular architectures, standardized interfaces, and service agreements that transfer certain risks to vendors. Clinically, tariff-driven disruptions can slow replacement cycles and delay the diffusion of newer, more capable systems, creating a temporal gap between capability availability and broad clinical adoption. As stakeholders recalibrate, the emphasis on robust supplier governance, multi-year procurement contracts, and strategic inventory management will grow.

An integrated segmentation perspective that links components, applications, users, technologies, deployments, and surgical procedures to reveal adoption drivers and value pools

A segmentation-aware view clarifies where value accrues and how investment priorities differ across product layers, clinical uses, and customer types. Component-level distinctions reveal that hardware remains foundational, with imaging systems, navigation systems, and robotic systems forming the tangible interface to the patient and clinical team, while services and software create the sustained operational and clinical value proposition. Integration, maintenance, and training services are increasingly pivotal for unlocking hardware utility, and AI platforms, analytics software, and predictive algorithms are the primary levers for improving intraoperative decision quality and workflow efficiency.

Application segmentation shapes requirements for latency, validation, and regulatory evidence. Intraoperative imaging modalities-CT, MRI, and ultrasound-have differing constraints and integration needs, while predictive analytics use cases such as outcome prediction and workflow optimization demand longitudinal clinical data and interoperability. Robotic assistance spans neuroendoscopic robots and robot-assisted microscopy, each with distinct control, haptics, and reliability expectations. End-user typologies, including ambulatory surgical centers, hospitals and clinics, and research institutes, create diverse procurement and deployment preferences that influence service models and support levels. Technology choices-computer vision with 3D reconstruction and image segmentation, deep learning instantiated through convolutional and recurrent architectures, machine learning with supervised and unsupervised approaches, and natural language processing applied to clinical report analysis and literature mining-determine validation pathways and compute requirements. Deployment options between cloud and on-premise environments influence data governance, latency, and upgrade cadence. Clinical procedure focus areas such as deep brain stimulation, epilepsy surgery, and tumor resection, and anatomical targets including brain and spinal cord, further refine requirements for precision, registration, and intraoperative feedback loops. Viewing the market through these intersecting segmentation lenses helps reveal where clinical need, technical feasibility, and procurement criteria align to accelerate adoption.

How distinct regulatory regimes, procurement models, and clinical infrastructures across the Americas, EMEA, and Asia-Pacific are shaping adoption trajectories and vendor strategies

Regional dynamics materially influence technology adoption, regulatory interaction, and clinical validation pathways. In the Americas, health systems often emphasize outcome-driven procurement, strong institutional research networks, and a willingness to invest in early clinical validation, which accelerates pilot programs and iterative deployments. The availability of specialized neurosurgical centers and concentrated academic hubs also supports rapid evidence generation and clinician training initiatives that catalyze broader uptake.

Across Europe, the Middle East and Africa, the regulatory landscape and reimbursement frameworks shape deployment timing and required evidence packages. Cost containment pressures in some jurisdictions increase demand for scalable, interoperable solutions that demonstrate clear improvements in throughput or clinical outcomes. Meanwhile, capacity constraints and uneven access to subspecialty care in parts of the region create opportunities for remote support models and cloud-enabled analytics to extend expertise. In the Asia-Pacific region, a combination of rapid hospital expansion, government-led technology adoption programs, and a competitive local manufacturing base drives heterogeneity in procurement strategies. The region often balances aggressive adoption of robotics and imaging with a strong emphasis on cost-effectiveness and supply chain resilience.

Competitive behaviors and strategic imperatives for companies pursuing leadership through integrated solutions, clinical evidence generation, and innovative commercial models

Key company behaviors cluster around several strategic priorities that determine market positioning and long-term competitiveness. First, firms that integrate end-to-end solutions-combining imaging or navigation hardware with validated AI software and robust service offerings-create higher switching costs for customers and can justify premium contracting models. Second, partnerships between clinical systems integrators, imaging vendors, and specialist AI developers are becoming the norm to accelerate regulatory submissions and clinical studies, sharing both risk and evidence-generation responsibilities.

Third, successful companies invest in longitudinal clinical validation and real-world evidence programs that demonstrate safety, reproducibility, and workflow impact; these programs are instrumental in gaining clinician trust and payer recognition. Fourth, firms that design for modularity and interoperability reduce integration friction with existing hospital infrastructures, which shortens procurement cycles. Finally, commercial models diversify beyond capital sales to include managed services, outcome-based contracts, and subscription licensing for analytics, aligning vendor incentives with clinical performance and operational uptime. Observing these behaviors helps inform competitive responses and potential partnership targets.

Actionable strategic moves for market leaders to accelerate adoption, de-risk deployments, and align commercial models with clinical outcomes and procurement realities

Industry leaders must pursue a balanced set of strategic moves that align clinical validation, procurement complexity, and technological differentiation. Prioritize building demonstrable clinical evidence through multi-center studies and clinician-led pilots that measure not only technical accuracy but also workflow impact, user acceptance, and downstream clinical outcomes. Simultaneously, structure commercial offers to reduce customer risk by bundling integration, training, and maintenance services with hardware and software, thereby lowering operational friction for early adopters.

To mitigate supply-chain and policy risks, diversify component sourcing and consider selective localization for critical assemblies. Invest in interoperable architectures and open APIs to ease integration with hospital information systems and existing imaging fleets. From a technology standpoint, focus development on explainable models and human-in-the-loop interfaces that enhance surgeon control and regulatory acceptability. Finally, cultivate partnerships with leading clinical centers and payers to build shared value propositions that link technology deployment to demonstrable improvements in clinical and operational metrics.

A robust multi-method research approach combining clinician interviews, technology assessment, regulatory review, and supply chain mapping to ensure evidence-based conclusions

The report's methodology combines primary research with rigorous secondary analysis and clinical validation to ensure findings are evidence-based and actionable. Primary inputs include structured interviews with practicing neurosurgeons, operating room nurses, biomedical engineers, hospital procurement officers, and technology executives, supplemented by direct observation of intraoperative workflows where available. These primary insights are triangulated with device technical specifications, regulatory filings, and peer-reviewed clinical literature to verify claims and contextualize results.

Technology assessments evaluate algorithmic approaches, training datasets, compute footprints, and integration complexity. Supply chain mapping traces component origins, assembly locations, and logistics risks to surface vulnerabilities. Regulatory reviews encompass device classification, approval timelines, and post-market surveillance obligations. Data synthesis employed a layered approach that weights clinical impact, technical readiness, and commercial viability to produce balanced recommendations while avoiding quantitative market sizing beyond the scope of qualitative and evidentiary analysis.

Concluding synthesis on how clinical validation, interoperable design, and resilient commercial strategies form the foundation for lasting adoption of AI in neurosurgery

Artificial intelligence is transitioning from a promising adjunct to a foundational layer that supports safer, more precise neurosurgical procedures. The technology's value is realized when hardware fidelity, validated algorithms, and service models coalesce to reduce intraoperative uncertainty, improve procedural efficiency, and extend specialist expertise. However, achieving this future depends on disciplined clinical validation, interoperable system design, resilient supply chains, and thoughtful commercial models that align incentives between vendors and clinical institutions.

Stakeholders who invest in modular architectures, longitudinal evidence programs, and strong clinician engagement programs will be best positioned to capture the clinical and economic benefits of AI-enabled neurosurgery. Policymakers and hospital leaders should encourage frameworks that reward demonstrable improvements in patient outcomes and operational performance, while vendors should emphasize explainability, reliability, and supportability as core product attributes. Taken together, these elements form the foundation for sustained, responsible adoption of AI in neurology operating rooms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Neurology Operating Room Market, by Component

  • 8.1. Hardware
    • 8.1.1. Imaging Systems
    • 8.1.2. Navigation Systems
    • 8.1.3. Robotic Systems
  • 8.2. Services
    • 8.2.1. Integration Services
    • 8.2.2. Maintenance Services
    • 8.2.3. Training Services
  • 8.3. Software
    • 8.3.1. AI Platforms
    • 8.3.2. Analytics Software
    • 8.3.3. Predictive Algorithms

9. Artificial Intelligence in Neurology Operating Room Market, by Technology

  • 9.1. Computer Vision
    • 9.1.1. 3D Reconstruction
    • 9.1.2. Image Segmentation
  • 9.2. Deep Learning
    • 9.2.1. Convolutional Neural Networks
    • 9.2.2. Recurrent Neural Networks
  • 9.3. Machine Learning
    • 9.3.1. Supervised Learning
    • 9.3.2. Unsupervised Learning
  • 9.4. Natural Language Processing
    • 9.4.1. Clinical Report Analysis
    • 9.4.2. Literature Mining

10. Artificial Intelligence in Neurology Operating Room Market, by Deployment

  • 10.1. Cloud
  • 10.2. On Premise

11. Artificial Intelligence in Neurology Operating Room Market, by Surgery Type

  • 11.1. Deep Brain Stimulation
  • 11.2. Epilepsy Surgery
  • 11.3. Tumor Resection

12. Artificial Intelligence in Neurology Operating Room Market, by Anatomy Target

  • 12.1. Brain
  • 12.2. Spinal Cord

13. Artificial Intelligence in Neurology Operating Room Market, by Application

  • 13.1. Intraoperative Imaging
    • 13.1.1. CT
    • 13.1.2. MRI
    • 13.1.3. Ultrasound
  • 13.2. Predictive Analytics
    • 13.2.1. Outcome Prediction
    • 13.2.2. Workflow Optimization
  • 13.3. Robotic Assistance
    • 13.3.1. Neuroendoscopic Robots
    • 13.3.2. Robot-Assisted Microscopy
  • 13.4. Surgical Navigation
    • 13.4.1. Electromagnetic Navigation
    • 13.4.2. Optical Navigation

14. Artificial Intelligence in Neurology Operating Room Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals And Clinics
  • 14.3. Research Institutes

15. Artificial Intelligence in Neurology Operating Room Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Artificial Intelligence in Neurology Operating Room Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Artificial Intelligence in Neurology Operating Room Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Artificial Intelligence in Neurology Operating Room Market

19. China Artificial Intelligence in Neurology Operating Room Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Activ Surgical Inc.
  • 20.6. Brainomix Limited
  • 20.7. Caresyntax Corporation
  • 20.8. DeepOR S.A.S.
  • 20.9. ExplORer Surgical Corp.
  • 20.10. GE HealthCare Technologies, Inc.
  • 20.11. Getinge AB
  • 20.12. Hill-Rom Holdings, Inc.
  • 20.13. Holo Surgical Inc.
  • 20.14. IMRIS inc.
  • 20.15. Johnson & Johnson Services, Inc.
  • 20.16. KARL STORZ SE & CO. KG
  • 20.17. Koninklijke Philips N.V.
  • 20.18. LeanTaaS Inc.
  • 20.19. Medtronic PLC
  • 20.20. NeuroOne Medical Technologies Corporation
  • 20.21. Proximie Limited
  • 20.22. Scalpel Limited
  • 20.23. Siemens Healthcare GmbH
  • 20.24. Stryker Corporation
  • 20.25. Surgalign Spine Technologies Inc.
  • 20.26. Surgical Theater, Inc.
  • 20.27. Theator Inc.
  • 20.28. Toshiba Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY UNSUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY UNSUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLINICAL REPORT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLINICAL REPORT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLINICAL REPORT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY LITERATURE MINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY LITERATURE MINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY LITERATURE MINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY EPILEPSY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY EPILEPSY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY EPILEPSY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY BRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY BRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY BRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SPINAL CORD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SPINAL CORD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SPINAL CORD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE ARTIFICIAL INTELL